Prescription drug · ANDA
Clomiphene Citrate NDC 83390-107
Clomiphene citrate 50 mg/1 · Tablet · Oral · Cosette Pharmaceuticals NC Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83390-107-09 | 83390010709 | 1 BLISTER PACK in 1 CARTON (83390-107-09) / 10 TABLET in 1 BLISTER PACKMarketed from Aug 21, 2025 | |
| 83390-107-30 | 83390010730 | 3 BLISTER PACK in 1 CARTON (83390-107-30) / 10 TABLET in 1 BLISTER PACKMarketed from Aug 21, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clomiphene Citrate
- Generic name (nonproprietary)
- clomiphene citrate
- Active ingredients
- Clomiphene citrate — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Cosette Pharmaceuticals NC Laboratories, LLCNDC labeler code 83390
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075528
- Marketing start
- Listing expires
- Other FDA classes
- Selective Estrogen Receptor Modulators (Mechanism)
- Identifiers
- Product ID 83390-107_3ce28083-f9f3-c59f-e063-6394a90a92e1SPL ID 3ce28083-f9f3-c59f-e063-6394a90a92e1SPL set ID 72719958-7454-4c54-9bb4-f3054d0c5d82RxCUI 1093060UNII 1B8447E7YI
- Pharmacologic class
- Estrogen Agonist/Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N483390010709followed by a unit qualifier and the quantityPackage 83390-0107-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS : Ovarian Hyperstimulation Syndrome ), amenorrhea-galactorrhea syndrome, psychogenic amenorrhea, post-oral-contraceptive amenorrhea, and certain cases of secondary amenorrhea of undetermined etiology. Properly timed coitus in relationship to ovulation is important. A basal body temperature graph or other appropriate tests…
Excerpt only. Read the full label for complete information.
About NDC 83390-107
- What is NDC 83390-107?
- 83390-107 is the product NDC for Clomiphene Citrate, Clomiphene citrate 50 mg/1 tablet, listed with the FDA by Cosette Pharmaceuticals NC Laboratories, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Clomiphene Citrate.
- What is the active ingredient?
- Clomiphene citrate.
- Who is the labeler?
- Cosette Pharmaceuticals NC Laboratories, LLC, NDC labeler code 83390. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Clomiphene Citrate?
- 7 other product NDCs are listed under this name. See all Clomiphene Citrate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Clomiphene Citrate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Clomiphene Citrate | Clomiphene citrate 50 mg/1 | TabletOral | Camber Pharmaceuticals Inc | 31722-541 | 31722-0541-3231722-0541-33 |
| Clomiphene Citrateclomiphene citrtae | Clomiphene citrate 50 mg/1 | TabletOral | Acetris Pharma Holdings, LLC | 52343-557 | 52343-0557-03 |
| Clomiphene Citrate | Clomiphene citrate 50 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-723 | 16729-0723-51 |
| Clomiphene citrate | Clomiphene citrate 50 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 70954-825 | 70954-0825-2070954-0825-30 |
| Clomiphene Citrateclomiphene citrtae | Clomiphene citrate 50 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | 64980-690 | 64980-0690-0164980-0690-0364980-0690-90 |
| Clomiphene Citrateclomiphene citrtae | Clomiphene citrate 50 mg/1 | TabletOral | Appco Pharma LLC | 55801-187 | 55801-0187-01 |
| Clomiphene Citrate | Clomiphene citrate 50 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-213 | 72888-0213-0872888-0213-58 |
Other NDCs under ANDA 075528
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clomidclomiphene citrate | Clomiphene citrate 50 mg/1 | TabletOral | Cosette Pharmaceuticals, Inc. | 0713-0885 |
| Clomidclomiphene citrate | Clomiphene citrate 50 mg/1 | TabletOral | A-S Medication Solutions | 50090-6500 |